Anti-Fracture Zoledronic Acid Injections Launched by Dr Reddy's in US

Drug firm Dr Reddy's Laboratories has launched its bioequivalent version of Zometa in the USA market following USFDA’s approval.

Hyderabad based drug firm Dr Reddy’s Laboratories has recently announced its launch of generic Zoledronic Acid injections in the US market.

The injection in 4 mg/5 ml strength is approved by the US Food and Drug Administration (USFDA) and is available in single use vials.

Anti-cancer Drug Causes Bone Loss
A drug commonly used to prevent breast cancer in post-menopausal women weakens bone density thus increasing fracture risk, reveals study.

The drug, which is a bioequivalent generic version of Novartis AG’s (NVS) Zometa, is used along with anti-cancer drugs to prevent bone fractures in patients with multiple myeloma and prostate cancer and for treating osteoporosis.

This has hiked the values of the firm’s share by nearly 1.06%.

Source-Medindia

New Discovery Shows Promise Against Bone Cancer
Researchers have discovered a gene pattern that may help to distinguish more severe form of bone cancer from a less aggressive one in dogs.